The role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: a systemic review and meta-analysis

医学 肝细胞癌 危险系数 内科学 优势比 置信区间 乙型肝炎 荟萃分析 胃肠病学 子群分析 慢性肝炎 肿瘤科 免疫学 病毒
作者
Qi-Hang Cao,Hui Liu,Lun-Jie Yan,Zi-Niu Ding,Long-Shan Yang,Xin-Chen Mao,Guo-Qiang Pan,Bao-Wen Tian,Chen-Long Han,Zhao-Ru Dong,Dong-Xu Wang,Yu-Chuan Yan,Tao Li
出处
期刊:Research Square - Research Square [Research Square (United States)]
标识
DOI:10.21203/rs.3.rs-3017876/v1
摘要

Abstract Background The purpose of the current study was to investigate the predictive value of hepatitis B core-related antigen (HBcrAg) on the occurrence and recurrence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Methods Based on PubMed, Embase, Scopus, and Web of Science, we conducted a systematic review and meta-analysis of original clinical literature. The primary outcomes were the occurrence and recurrence of HCC assessed by the hazard ratio (HR) or odds ratio (OR) with 95% confidence interval (CI). Results A total of 18 publications with 9039 CHB patients were included in the preliminary analysis. The pooled results suggest that HBcrAg positivity (adjusted HR = 3.10, 95%CI: 2.07–4.64, P < 0.001, I 2 = 62.4%, P = 0.021; OR = 5.65, 95%CI: 3.44–5.82, P < 0.001, I 2 = 0.00%, P = 0.42) was an independent risk factor for the occurrence of HCC. Further subgroup analysis revealed that 4.0 logU/ml may be the optimal cut-off value for HBcrAg to predict the occurrence of HCC. Our meta-analysis also suggests that HBcrAg is a predictor of HCC recurrence during antiviral therapy (adjusted HR = 1.71, 95%CI: 1.26–2.32; I 2 = 78.6%, P = 0.031) and is closely related to recurrence-free survival (RFS) after curative treatment of HCC (P = 0.001). Conclusion For patients with CHB, serum HBcrAg level is closely associated with the occurrence of HCC, regardless of whether nucleoside/nucleotide analogues (NAs) are administered, may also serve as a novel prognostic biomarker of recurrence in HCC. Confirmation of these findings requires more research.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
stupid完成签到,获得积分10
刚刚
研友_LaOyQZ完成签到,获得积分10
1秒前
Jun举报大肘子的求助涉嫌违规
1秒前
1秒前
小杰发布了新的文献求助10
2秒前
深情安青的应助被愉快幻天采纳,获得30
2秒前
2秒前
Code_king发布了新的文献求助10
3秒前
小二郎的应助被我不吃饭采纳,获得10
3秒前
Code_king发布了新的文献求助10
3秒前
可爱的函函的应助被Yuer采纳,获得10
3秒前
Code_king发布了新的文献求助10
3秒前
Amost完成签到,获得积分10
3秒前
stupid发布了新的文献求助20
4秒前
yccsg完成签到,获得积分10
4秒前
哈哈哈完成签到,获得积分10
4秒前
4秒前
天天向上的应助被wangting采纳,获得10
4秒前
林梓发布了新的文献求助30
4秒前
syvshc的应助被青山不复采纳,获得10
4秒前
迷人乐珍完成签到,获得积分20
5秒前
5秒前
时间完成签到,获得积分10
5秒前
脑洞疼的应助被5322采纳,获得30
5秒前
joshar发布了新的文献求助10
5秒前
活A完成签到,获得积分10
5秒前
6秒前
黑早早发布了新的文献求助10
7秒前
7秒前
栗子完成签到,获得积分10
7秒前
xls完成签到 ,获得积分10
8秒前
8秒前
小二郎的应助被summer采纳,获得10
8秒前
科研通AI6.2的应助被活A采纳,获得10
8秒前
sufu_jony的应助被Code_king采纳,获得10
9秒前
自然的南珍的应助被Code_king采纳,获得10
9秒前
美满懿轩发布了新的文献求助10
9秒前
汉堡包的应助被Code_king采纳,获得10
9秒前
living笑白完成签到,获得积分10
9秒前
Ava的应助被Code_king采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8176174
求助须知:如何正确求助?哪些是违规求助? 9567656
关于积分的说明 21793895
捐赠科研通 7770887
什么是DOI,文献DOI怎么找? 3431991
关于科研通互助平台的介绍 2556313
邀请新用户注册赠送积分活动 2477540